LV BODY BOOST Trademark

Trademark Overview

On Wednesday, February 5, 2025, a trademark application was filed for LV BODY BOOST with the United States Patent and Trademark Office. The USPTO has given the LV BODY BOOST trademark a serial number of 99030017. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 22, 2025. This trademark is owned by Jace Investment Holdings LLC. The LV BODY BOOST trademark is filed in the Advertising, Business and Retail Services category with the following description:

On-line wholesale and retail store services featuring supplements, wellness products, semaglutide, tirzepatide, testosterone, and other prescription or non-prescription drugs. It also covers hormone replacement therapy (HRT), peptides, and weight loss medications.
lv body boost

General Information

Serial Number99030017
Word MarkLV BODY BOOST
Filing DateWednesday, February 5, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesOn-line wholesale and retail store services featuring supplements, wellness products, semaglutide, tirzepatide, testosterone, and other prescription or non-prescription drugs. It also covers hormone replacement therapy (HRT), peptides, and weight loss medications.

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, February 5, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJace Investment Holdings LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHenderson, NV 89052

Trademark Events

Event DateEvent Description
Wednesday, February 5, 2025NEW APPLICATION ENTERED
Monday, July 7, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 15, 2025ASSIGNED TO EXAMINER
Tuesday, July 22, 2025NON-FINAL ACTION WRITTEN
Tuesday, July 22, 2025NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 5, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

boost body prescription hormone covers drugs replacement also therapy medications loss weight